These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33036756)

  • 1. An actin-WHAMM interaction linking SETD2 and autophagy.
    Seervai RNH; Grimm SL; Jangid RK; Tripathi DN; Coarfa C; Walker CL
    Biochem Biophys Res Commun; 2021 Jun; 558():202-208. PubMed ID: 33036756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SETD2 mutation in renal clear cell carcinoma suppress autophagy via regulation of ATG12.
    González-Rodríguez P; Engskog-Vlachos P; Zhang H; Murgoci AN; Zerdes I; Joseph B
    Cell Death Dis; 2020 Jan; 11(1):69. PubMed ID: 31988284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Huntingtin-interacting protein SETD2/HYPB is an actin lysine methyltransferase.
    Seervai RNH; Jangid RK; Karki M; Tripathi DN; Jung SY; Kearns SE; Verhey KJ; Cianfrocco MA; Millis BA; Tyska MJ; Mason FM; Rathmell WK; Park IY; Dere R; Walker CL
    Sci Adv; 2020 Oct; 6(40):. PubMed ID: 33008892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WHAMM initiates autolysosome tubulation by promoting actin polymerization on autolysosomes.
    Dai A; Yu L; Wang HW
    Nat Commun; 2019 Aug; 10(1):3699. PubMed ID: 31420534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-106b-5p targets tumor suppressor gene SETD2 to inactive its function in clear cell renal cell carcinoma.
    Xiang W; He J; Huang C; Chen L; Tao D; Wu X; Wang M; Luo G; Xiao X; Zeng F; Jiang G
    Oncotarget; 2015 Feb; 6(6):4066-79. PubMed ID: 25714014
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Chiang YC; Park IY; Terzo EA; Tripathi DN; Mason FM; Fahey CC; Karki M; Shuster CB; Sohn BH; Chowdhury P; Powell RT; Ohi R; Tsai YS; de Cubas AA; Khan A; Davis IJ; Strahl BD; Parker JS; Dere R; Walker CL; Rathmell WK
    Cancer Res; 2018 Jun; 78(12):3135-3146. PubMed ID: 29724720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WHAMM Directs the Arp2/3 Complex to the ER for Autophagosome Biogenesis through an Actin Comet Tail Mechanism.
    Kast DJ; Zajac AL; Holzbaur EL; Ostap EM; Dominguez R
    Curr Biol; 2015 Jun; 25(13):1791-7. PubMed ID: 26096974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of SETD2, but not H3K36me3, correlates with aggressive clinicopathological features of clear cell renal cell carcinoma patients.
    Liu L; Guo R; Zhang X; Liang Y; Kong F; Wang J; Xu Z
    Biosci Trends; 2017 May; 11(2):214-220. PubMed ID: 28260718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WHAMM functions in kidney reabsorption and polymerizes actin to promote autophagosomal membrane closure and cargo sequestration.
    Coulter AM; Cortés V; Theodore CJ; Cianciolo RE; Korstanje R; Campellone KG
    Mol Biol Cell; 2024 Jun; 35(6):ar80. PubMed ID: 38598293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Genomic and Proteomic Analyses Reveal Novel Mechanisms of the Methyltransferase SETD2 in Renal Cell Carcinoma Development.
    Li L; Miao W; Huang M; Williams P; Wang Y
    Mol Cell Proteomics; 2019 Mar; 18(3):437-447. PubMed ID: 30487242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair.
    Kanu N; Grönroos E; Martinez P; Burrell RA; Yi Goh X; Bartkova J; Maya-Mendoza A; Mistrík M; Rowan AJ; Patel H; Rabinowitz A; East P; Wilson G; Santos CR; McGranahan N; Gulati S; Gerlinger M; Birkbak NJ; Joshi T; Alexandrov LB; Stratton MR; Powles T; Matthews N; Bates PA; Stewart A; Szallasi Z; Larkin J; Bartek J; Swanton C
    Oncogene; 2015 Nov; 34(46):5699-708. PubMed ID: 25728682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHAMM links actin assembly via the Arp2/3 complex to autophagy.
    Kast DJ; Dominguez R
    Autophagy; 2015; 11(9):1702-4. PubMed ID: 26291929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Studies on Primary Tubular Epithelial Cells Indicate a Tumor Suppressor Role of SETD2 in Clear Cell Renal Cell Carcinoma.
    Li J; Kluiver J; Osinga J; Westers H; van Werkhoven MB; Seelen MA; Sijmons RH; van den Berg A; Kok K
    Neoplasia; 2016 Jun; 18(6):339-46. PubMed ID: 27292023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma.
    Ho TH; Park IY; Zhao H; Tong P; Champion MD; Yan H; Monzon FA; Hoang A; Tamboli P; Parker AS; Joseph RW; Qiao W; Dykema K; Tannir NM; Castle EP; Nunez-Nateras R; Teh BT; Wang J; Walker CL; Hung MC; Jonasch E
    Oncogene; 2016 Mar; 35(12):1565-74. PubMed ID: 26073078
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Su X; Zhang J; Mouawad R; Compérat E; Rouprêt M; Allanic F; Parra J; Bitker MO; Thompson EJ; Gowrishankar B; Houldsworth J; Weinstein JN; Tost J; Broom BM; Khayat D; Spano JP; Tannir NM; Malouf GG
    Cancer Res; 2017 Sep; 77(18):4835-4845. PubMed ID: 28754676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SETD2 is required for DNA double-strand break repair and activation of the p53-mediated checkpoint.
    Carvalho S; Vítor AC; Sridhara SC; Martins FB; Raposo AC; Desterro JM; Ferreira J; de Almeida SF
    Elife; 2014 May; 3():e02482. PubMed ID: 24843002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI3Kβ inhibitor TGX221 selectively inhibits renal cell carcinoma cells with both VHL and SETD2 mutations and links multiple pathways.
    Sci Rep; ; . PubMed ID: 25853938
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.